904 related articles for article (PubMed ID: 17898327)
1. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
[TBL] [Abstract][Full Text] [Related]
2. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan.
Nagasawa K; Kuwabara S; Misawa S; Fujii K; Tanabe Y; Yuki N; Hattori T; Kohno Y
Muscle Nerve; 2006 Jun; 33(6):766-70. PubMed ID: 16506153
[TBL] [Abstract][Full Text] [Related]
4. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
5. [Guillain Barré syndrome in pediatrics].
Erazo Torricelli R
Medicina (B Aires); 2009; 69(1 Pt 1):84-91. PubMed ID: 19240005
[TBL] [Abstract][Full Text] [Related]
6. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
[TBL] [Abstract][Full Text] [Related]
9. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
[TBL] [Abstract][Full Text] [Related]
10. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
Yuki N; Kuwabara S
J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
[TBL] [Abstract][Full Text] [Related]
11. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital.
Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S
Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657
[TBL] [Abstract][Full Text] [Related]
12. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes.
Mitsui Y; Kusunoki S; Arimura K; Kaji R; Kanda T; Kuwabara S; Sonoo M; Takada K;
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):110-4. PubMed ID: 24273220
[TBL] [Abstract][Full Text] [Related]
13. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
[TBL] [Abstract][Full Text] [Related]
14. Serologic marker of acute motor axonal neuropathy in childhood.
Nishimoto Y; Susuki K; Yuki N
Pediatr Neurol; 2008 Jul; 39(1):67-70. PubMed ID: 18555178
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barre syndrome and Campylobacter infection.
Prasad KN; Pradhan S; Nag VL
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):527-30. PubMed ID: 11944711
[TBL] [Abstract][Full Text] [Related]
16. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
[TBL] [Abstract][Full Text] [Related]
17. Evolving pattern of Guillain-Barre syndrome in a community hospital in Israel.
Kushnir M; Klein C; Pollak L; Rabey JM
Acta Neurol Scand; 2008 May; 117(5):347-50. PubMed ID: 17995988
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological subtypes and prognosis of Guillain-Barré syndrome in northeastern China.
Ye Y; Wang K; Deng F; Xing Y
Muscle Nerve; 2013 Jan; 47(1):68-71. PubMed ID: 23042578
[TBL] [Abstract][Full Text] [Related]
19. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
20. How Different is AMAN from AIDP in Childhood GBS? A Prospective Study from North India.
Gupta PK; Singhi P; Singhi S; Kasinathan A; Sankhyan N
Indian J Pediatr; 2019 Apr; 86(4):329-334. PubMed ID: 30637680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
